Why the study?
Does topical prostaglandin treatment prevent eyelash loss in patients undergoing chemotherapy?
Case Report
Does topical prostaglandin treatment prevent eyelash loss in patients undergoing chemotherapy?
Topical prostaglandins may offer a cytoprotective effect against chemotherapy-induced hair follicle injury, specifically preserving eyelashes.
Should not yet change practice for chemotherapy-induced eyelash loss; single case leaves open a cytoprotective hypothesis requiring controlled trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Katherine Esposito (2010) conducted a case report in Chemotherapy-induced hair loss. Topical prostaglandins was evaluated on Eyelash preservation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: